Infarct size--can it be measured or modified in humans?

Area of Science:

• Cardiology
• Cardiovascular Research

Background:

• Over 15 years of research has focused on limiting infarct size.
• No treatment is currently recommended for routine use due to efficacy and side effect concerns.
• Ideal methods for measuring infarct size are still lacking.

Purpose of the Study:

• To review progress in understanding myocardial infarct mechanisms.
• To highlight advancements in infarct size measurement and therapeutic interventions.
• To discuss the potential of combined reperfusion and pharmacologic therapies.

Main Methods:

• Review of experimental and clinical research on infarct size limitation.
• Analysis of mechanisms of cellular injury in myocardial infarction.
• Evaluation of current and emerging techniques for infarct sizing and functional assessment.

Main Results:

• Significant progress in understanding irreversible cellular injury and factors contributing to infarct development.
• Availability of rapid coronary thrombolysis interventions.
• Development of advanced techniques for infarct sizing and ventricular function estimation.

Conclusions:

• Despite challenges, understanding of myocardial infarction mechanisms has advanced.
• Emerging therapies, including combined reperfusion and pharmacologic interventions, show promise.
• Limiting infarct size and preserving ventricular function remain critical areas for future clinical research.